Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trinucleotide repeat containing 18 pseudogene 2 (TNRC18P2) is classified as a human pseudogene, meaning it is a DNA sequence similar to a known gene (TNRC18) but generally lacks the ability to code for a functional protein due to mutations or regulatory changes[5]. Pseudogenes like TNRC18P2 may result from gene duplication or retrotransposition, and while some pseudogenes play regulatory roles or are transcribed, TNRC18P2 does not have established biological functions or relevance as a therapeutic or diagnostic target. The relevant protein-coding gene with a similar name, TNRC18, is involved in chromatin binding and is not a receptor or enzyme, but TNRC18P2 itself does not code for protein and does not belong to major target families such as G protein-coupled receptors, ion channels, or enzymes[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trinucleotide repeat containing 18 pseudogene 2 (TNRC18P2).